The experimental COVID-19 vaccine being developed by AstraZeneca and Oxford University produces a strong immune response in older adults, data from early trials have shown.

from MarketWatch.com - Top Stories https://ift.tt/2IQPmMn
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2IQPmMn
via IFTTT
Kommentare
Kommentar veröffentlichen